DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the FABTECH TECHNOLOGIES LTD (FABTECH) share price today?

FABTECH TECHNOLOGIES LTD (FABTECH) is trading at ₹153.71 on the NSE, down 1.87% on the day. Source: DocStoX.

What is the PE ratio of FABTECH TECHNOLOGIES LTD?

FABTECH TECHNOLOGIES LTD has a price-to-earnings (PE) ratio of 17.8 in the Healthcare sector.

What is the market capitalisation of FABTECH TECHNOLOGIES LTD?

FABTECH TECHNOLOGIES LTD has a market capitalisation of approximately ₹676 crore.

FABTECH TECHNOLOGIES LTD

FABTECH·NSE·Healthcare

₹153.71▼ -2.93 (-1.87%)

Healthcare · Medical Equipment

Revenue compounding 28% a year

Day₹152.65

₹158.00

52W₹133

₹26316%

Open

₹157.41

High

₹158.00

Low

₹152.65

Prev Close

₹156.64

Volume

1.37L

VWAP

₹155.02

Snapshot

Key fundamentals

Market Cap

₹676 Cr

P/E Ratio

17.81Fair

P/B Ratio

1.71

EPS

₹8.63

Book Value

₹94.40

ROE

12.50%Average

ROCE

14.00%Decent

Dividend Yield

0.37%

Debt / Equity

0.17Low

Face Value

₹10.00

52W High

₹262.80

52W Low

₹132.70

Sector

Healthcare

Industry

Medical Equipment

Avoid

None moatMedium uncertainty

Fair value estimate

₹104

▼ 32.0%downside

Trading at ₹154 — 32% above our estimate

BearFair valueBull

₹89₹104₹135

/100

Business quality — Solid

Growth 90Profitability 39Efficiency 15Valuation 86

Plain English

Our view

Revenue compounding 28% a year
Low debt relative to equity
Fundamental red flags (Piotroski 0/9)

Strengths

Low debt relative to equity
Revenue compounding 28% over 3 years
Profit growing 20% a year
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 0/9)

How we got there

Fair value methods

Residual income

13% ROE fading to 12% over ~3 yrs, on ₹94 book

₹96

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹135

Analyst target

No analyst coverage

—

Blended fair value₹104

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 28% over 3 years
Profit growing 20% a year
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 0/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

17.8Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

12.5%Average

Above 15% is considered healthy for Indian equities

ROCE

14.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.17Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹676 Cr

P/B

1.71

EPS

₹8.63

Div Yield

0.37%

What changed

Recent changes

Domestic institutions+0.3% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 17.8×

Growth

Strong

+28% rev CAGR

Profitability

Healthy

12.5% ROE

Financial health

Rock solid

D/E 0.17

Momentum

N/A

No technicals

Today

Trading activity

Delivery %34.8%

Turnover₹213.04L Cr

Trades2,384

VWAP₹155.02

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+28.4%

+27.7%

10Y

—

Profit

+20.0%

+36.6%

10Y

—

EPS

-52.0%

-74.5%

10Y

—

Profile

Pros

Company has delivered good profit growth of 35.8% CAGR over last 5 years

Watch-outs

Cons

Earnings include an other income of Rs.22.7 Cr.
Company has high debtors of 182 days.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions added 0.30 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

69%

Promoter

Promoters

68.9%0.00

Public

28.6%-0.26

FII / FPI

0.0%-0.06

DII

2.5%+0.30

Quarterly trend

Ownership over time

Q1 FY27

Promoter68.94%

FII0.02%

DII2.45%

Public28.57%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.[1]